Results 311 to 320 of about 160,832 (337)

Gemcitabine

Reactions Weekly, 2009
openaire   +1 more source

Gemcitabine

Reactions Weekly, 2019
openaire   +2 more sources

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Journal of Clinical Oncology, 2008
Giorgio Scagliotti, Johan Filip Vansteenkiste, Digumarti Raghunadha Rao   +2 more
exaly  

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

Lancet Oncology, The, 2014
Yi-Long Wu, Shun Lu, Yunchao Huang
exaly  

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Lancet, The, 2016
Katshuhiko Uesaka, Narikazu Boku, Yukiyasu Okamura   +2 more
exaly  

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Lancet, The, 2016
Andrea Wang-Gillam, Chung-Pin Li, György Bodoky   +2 more
exaly  

In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy

Science Translational Medicine, 2018
Chao Wang, Jinqiang Wang, Xudong Zhang
exaly  

Gemcitabine

Reactions Weekly, 2022
openaire   +1 more source

Gemcitabine

Reactions Weekly, 2017
openaire   +2 more sources

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

New England Journal of Medicine, 2013
Daniel D Von Hoff, E Gabriela Chiorean, Reni Michele   +2 more
exaly